Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine effects on treatment of COVID-19
IRCT20190804044429N5Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Feb 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of colchicine in coronavirus pneumonia, sponsored by Mazandaran University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
colchicine
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20190804044429N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190804044429N5.